Comparison of machine-learning methodologies for accurate diagnosis of sepsis using microarray gene expression data.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 09 02 2021
accepted: 04 05 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 21 10 2021
Statut: epublish

Résumé

We investigate the feasibility of molecular-level sample classification of sepsis using microarray gene expression data merged by in silico meta-analysis. Publicly available data series were extracted from NCBI Gene Expression Omnibus and EMBL-EBI ArrayExpress to create a comprehensive meta-analysis microarray expression set (meta-expression set). Measurements had to be obtained via microarray-technique from whole blood samples of adult or pediatric patients with sepsis diagnosed based on international consensus definition immediately after admission to the intensive care unit. We aggregate trauma patients, systemic inflammatory response syndrome (SIRS) patients, and healthy controls in a non-septic entity. Differential expression (DE) analysis is compared with machine-learning-based solutions like decision tree (DT), random forest (RF), support vector machine (SVM), and deep-learning neural networks (DNNs). We evaluated classifier training and discrimination performance in 100 independent iterations. To test diagnostic resilience, we gradually degraded expression data in multiple levels. Clustering of expression values based on DE genes results in partial identification of sepsis samples. In contrast, RF, SVM, and DNN provide excellent diagnostic performance measured in terms of accuracy and area under the curve (>0.96 and >0.99, respectively). We prove DNNs as the most resilient methodology, virtually unaffected by targeted removal of DE genes. By surpassing most other published solutions, the presented approach substantially augments current diagnostic capability in intensive care medicine.

Identifiants

pubmed: 33999966
doi: 10.1371/journal.pone.0251800
pii: PONE-D-21-04463
pmc: PMC8128240
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0251800

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Crit Care Med. 2019 Dec;47(12):1782-1784
pubmed: 31162195
Clin Vaccine Immunol. 2008 Jul;15(7):1089-94
pubmed: 18480235
Pediatrics. 2014 May;133(5):e1203-11
pubmed: 24709930
Physiol Genomics. 2007 Jul 18;30(2):146-55
pubmed: 17374846
BMC Med. 2009 Jul 22;7:34
pubmed: 19624809
Physiol Genomics. 2006 Feb 14;24(3):298-309
pubmed: 16478828
Crit Care Med. 2018 Feb;46(2):244-251
pubmed: 29337789
PLoS One. 2013;8(1):e48979
pubmed: 23326304
Crit Care Med. 2007 Apr;35(4):1105-12
pubmed: 17334251
BMC Bioinformatics. 2007 Feb 01;8:35
pubmed: 17270037
Am J Physiol Lung Cell Mol Physiol. 2015 Jun 1;308(11):L1102-13
pubmed: 25795726
Intensive Care Med. 2020 Mar;46(3):383-400
pubmed: 31965266
Genome Biol. 2009;10(11):R127
pubmed: 19903332
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Shock. 2013 Sep;40(3):166-74
pubmed: 23807251
Am J Respir Crit Care Med. 2018 Oct 1;198(7):903-913
pubmed: 29624409
Physiol Genomics. 2008 Jun 12;34(1):127-34
pubmed: 18460642
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
PLoS One. 2018 Jun 19;13(6):e0198555
pubmed: 29920518
Intensive Care Med. 2015 Sep;41(9):1620-8
pubmed: 26109396
PLoS Med. 2016 May 17;13(5):e1002022
pubmed: 27187803
PLoS Med. 2015 Dec 08;12(12):e1001916
pubmed: 26645559
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9923-8
pubmed: 20479259
Mol Med. 2011;17(11-12):1146-56
pubmed: 21738952
Nat Commun. 2014 Aug 14;5:4649
pubmed: 25120092
Crit Care. 2011 Jun 20;15(3):R149
pubmed: 21682927
Hum Immunol. 2017 May - Jun;78(5-6):441-450
pubmed: 28341250
Crit Care Med. 2009 May;37(5):1558-66
pubmed: 19325468
Comput Biol Med. 2017 Oct 1;89:248-255
pubmed: 28843829
Crit Care Med. 2017 Jan;45(1):1-10
pubmed: 27681387
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1225-34
pubmed: 22461369
Intensive Care Med Exp. 2014 Dec;2(1):20
pubmed: 26215705
Am J Respir Crit Care Med. 2015 Oct 1;192(7):826-35
pubmed: 26121490
Lancet Respir Med. 2016 Apr;4(4):259-71
pubmed: 26917434
J Exp Med. 2011 Dec 19;208(13):2581-90
pubmed: 22110166
Am J Respir Crit Care Med. 2017 Aug 1;196(3):328-339
pubmed: 28036233
Comput Methods Programs Biomed. 2019 Mar;170:1-9
pubmed: 30712598
Sci Transl Med. 2014 Sep 24;6(255):255ra132
pubmed: 25253675
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Crit Care. 2017 Jun 16;21(1):158
pubmed: 28623938
Physiol Genomics. 2009 Apr 10;37(2):133-9
pubmed: 19174476

Auteurs

Dominik Schaack (D)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.

Markus A Weigand (MA)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.

Florian Uhle (F)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH